All Stories
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
-
Find DaVita at ViVE in Los Angeles!
Every year, ViVE brings together health care leaders — from executives and policy makers to senior digital health leaders, buyers and solution providers — to weigh in on digital health. This year,
-
Teamwork in Treatment: Recognizing the Essential Role Care Partners Play in Home Dialysis
When Claire started dialysis, her in-center treatments made her feel like she was missing out. She enjoyed an active lifestyle, regular outings with her friends and rounds of golf. So when she and…
-
Research with Stanford Illustrates Importance of Non-Clinical Well-Being Factors
In a recent article from the New England Journal of Medicine (NEJM) Catalyst,[1] researchers from Stanford University’s Clinical Excellence Research Center and DaVita Kidney Care shared findings…
-
We Give Life: Melanie Chats with DaVita CEO Javier Rodriguez
As a college student, Melanie’s first priorities were doing well in school and pursuing her career goals. “Then all of a sudden, my life completely changed,” Melanie says. A kidney biopsy…
-
Our Strategy to Help Eliminate the Nursing Workforce Shortage
Since I became DaVita Kidney Care’s chief nursing officer in October 2021, one aspect of my job I’ve loved the most is the opportunity to host nursing roundtables across the country. It’s an…